Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies

Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies

US Patent 11633506 · Granted Apr 25, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2025
PSMA-targeting ligands with optimal properties for imaging and therapy2025
PSMA-targeting ligands with optimal properties for imaging and therapy2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Remote insect detector2024
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Multi-purpose catheter for brachytherapy and intratumoral injection2023